GlobeNewswire

October 15, 2021 Off

PLx Pharma, Inc. Issues Statement on Recent USPTF Recommendations on Aspirin Therapy for Primary Prevention of Cardiovascular Disease; PLx’s VAZALORE Specifically Indicated for Secondary Prevention

Aspirin remains an established practice for the prevention of another heart attack or clot-related strokeSPARTA, N.J., Oct. 14, 2021 (GLOBE…

October 15, 2021 Off

Todos Medical to Conduct Webinar Highlighting the cPass SARS-COV-2 Neutralizing Antibody Test for AMDA, The Society for Post-Acute and Long-Term Care Medicine, on October 22, 2021 at 12:00 PM EDT

By GlobeNewswire

Dr. Jorge Leone, Chief Scientific Officer of Todos Medical, and Sean Taylor, North American FAS Manager of Genscript, will discuss the…

October 15, 2021 Off

Vaxil Signs Letter of Intent to Acquire a 100% Interest in Short Wave Pharma Inc.

By GlobeNewswire

Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Oct. 14, 2021 (GLOBE NEWSWIRE) — VAXIL BIO…

October 15, 2021 Off

TG Therapeutics Announces Data for Ublituximab in Multiple Sclerosis Presented at the 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis

By GlobeNewswire

New ULTIMATE I & II data presented at ECTRIMS shows ublituximab treatment is associated with significant improvement in the multiple…

October 13, 2021 Off

Relay Therapeutics Announces Pricing of Public Offering of Common Stock

By GlobeNewswire

CAMBRIDGE, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the…

October 13, 2021 Off

Fireside Chat with Enochian BioSciences’ CEO, Dr. Mark Dybul at H.C. Wainwright 2nd Annual Hepatitis B Virus (HBV) Conference

By GlobeNewswire

LOS ANGELES, Oct. 12, 2021 (GLOBE NEWSWIRE) — (NASDAQ: ENOB) − Enochian BioSciences, a company focused on gene-modified cellular and…

October 13, 2021 Off

Travere Therapeutics Announces Transition of Chief Medical Officer

By GlobeNewswire

SAN DIEGO, Oct. 12, 2021 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that its chief medical officer,…

October 13, 2021 Off

Cellectis to Present Preclinical Data on UCARTMESO Supporting Anti-Tumor Activity at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting

By GlobeNewswire

NEW YORK, Oct. 12, 2021 (GLOBE NEWSWIRE) — Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS) (the “Company”), a gene-editing…

October 13, 2021 Off

Resverlogix Receives Ethics Approval for Canadian Sites in Apabetalone COVID-19 Clinical Trial

By GlobeNewswire

Study Approval Paves the Way for Trial Participants to Begin Taking ApabetaloneCALGARY, Alberta, Oct. 12, 2021 (GLOBE NEWSWIRE) — Resverlogix…

October 13, 2021 Off

Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2021

By GlobeNewswire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of September…